{"entity":{"type":"insider","cik":"0001380185","url":"/insider/0001380185","json_url":"/insider/0001380185.json","name":"El-Hibri Fuad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":336,"n_filings":104,"first":"2008-07-28","last":"2020-11-12","span_basis":"filed_date"},"name_variants":[{"name":"El-Hibri Fuad","source":"filing","n_filings":104,"first_seen":"2008-07-28","last_seen":"2020-11-12"}],"transactions":[{"id":2208660,"accession":"0000899243-20-030866","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030866","line_url":"/filing/0000899243-20-030866#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19391.0,"shares_display":"19,391","price_per_share":88.21,"price_display":"88.21","price_state":"stated","total_value":1710480.11,"total_display":"1,710,480.11","total_whole":"1,710,480","shares_owned_after":1123988.0,"shares_owned_after_display":"1,123,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2208649,"accession":"0000899243-20-030866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030866","line_url":"/filing/0000899243-20-030866#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":95.26,"price_display":"95.26","price_state":"stated","total_value":1905200.0,"total_display":"1,905,200.00","total_whole":"1,905,200","shares_owned_after":1123988.0,"shares_owned_after_display":"1,123,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-12","scope":"insider"},{"id":2045222,"accession":"0000899243-20-030431","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030431","line_url":"/filing/0000899243-20-030431#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":90.74,"price_display":"90.74","price_state":"stated","total_value":1814800.0,"total_display":"1,814,800.00","total_whole":"1,814,800","shares_owned_after":1123988.0,"shares_owned_after_display":"1,123,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-04","scope":"insider"},{"id":2045220,"accession":"0000899243-20-030431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030431","line_url":"/filing/0000899243-20-030431#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":90.44,"price_display":"90.44","price_state":"stated","total_value":1808800.0,"total_display":"1,808,800.00","total_whole":"1,808,800","shares_owned_after":1123988.0,"shares_owned_after_display":"1,123,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":2208249,"accession":"0000899243-20-026348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-026348","line_url":"/filing/0000899243-20-026348#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12535.0,"shares_display":"12,535","price_per_share":98.85,"price_display":"98.85","price_state":"stated","total_value":1239084.75,"total_display":"1,239,084.75","total_whole":"1,239,085","shares_owned_after":1123988.0,"shares_owned_after_display":"1,123,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-24","filed_date":"2020-09-25","scope":"insider"},{"id":2208242,"accession":"0000899243-20-026348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-026348","line_url":"/filing/0000899243-20-026348#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":100.58,"price_display":"100.58","price_state":"stated","total_value":1307540.0,"total_display":"1,307,540.00","total_whole":"1,307,540","shares_owned_after":1136523.0,"shares_owned_after_display":"1,136,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-25","scope":"insider"},{"id":3112136,"accession":"0000899243-20-025750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-025750","line_url":"/filing/0000899243-20-025750#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":100.68,"price_display":"100.68","price_state":"stated","total_value":2013600.0,"total_display":"2,013,600.00","total_whole":"2,013,600","shares_owned_after":1149523.0,"shares_owned_after_display":"1,149,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-18","scope":"insider"},{"id":3112129,"accession":"0000899243-20-025750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-025750","line_url":"/filing/0000899243-20-025750#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":102.48,"price_display":"102.48","price_state":"stated","total_value":2049600.0,"total_display":"2,049,600.00","total_whole":"2,049,600","shares_owned_after":1169523.0,"shares_owned_after_display":"1,169,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-16","filed_date":"2020-09-18","scope":"insider"},{"id":2287888,"accession":"0000899243-20-024940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-024940","line_url":"/filing/0000899243-20-024940#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":102.66,"price_display":"102.66","price_state":"stated","total_value":2053200.0,"total_display":"2,053,200.00","total_whole":"2,053,200","shares_owned_after":1189523.0,"shares_owned_after_display":"1,189,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-11","scope":"insider"},{"id":2287883,"accession":"0000899243-20-024940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-024940","line_url":"/filing/0000899243-20-024940#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":102.8,"price_display":"102.80","price_state":"stated","total_value":2056000.0,"total_display":"2,056,000.00","total_whole":"2,056,000","shares_owned_after":1209523.0,"shares_owned_after_display":"1,209,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-11","scope":"insider"},{"id":2057565,"accession":"0000899243-20-011765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-011765","line_url":"/filing/0000899243-20-011765#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":74.01,"price_display":"74.01","price_state":"stated","total_value":1480200.0,"total_display":"1,480,200.00","total_whole":"1,480,200","shares_owned_after":1229523.0,"shares_owned_after_display":"1,229,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-01","scope":"insider"},{"id":2057562,"accession":"0000899243-20-011765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-011765","line_url":"/filing/0000899243-20-011765#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":74.24,"price_display":"74.24","price_state":"stated","total_value":1484800.0,"total_display":"1,484,800.00","total_whole":"1,484,800","shares_owned_after":1249523.0,"shares_owned_after_display":"1,249,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-29","filed_date":"2020-05-01","scope":"insider"},{"id":3032785,"accession":"0000899243-20-011283","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-011283","line_url":"/filing/0000899243-20-011283#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":68.49,"price_display":"68.49","price_state":"stated","total_value":1369800.0,"total_display":"1,369,800.00","total_whole":"1,369,800","shares_owned_after":1269523.0,"shares_owned_after_display":"1,269,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-23","filed_date":"2020-04-24","scope":"insider"},{"id":3032781,"accession":"0000899243-20-011283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-011283","line_url":"/filing/0000899243-20-011283#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":66.81,"price_display":"66.81","price_state":"stated","total_value":1336200.0,"total_display":"1,336,200.00","total_whole":"1,336,200","shares_owned_after":1289523.0,"shares_owned_after_display":"1,289,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-22","filed_date":"2020-04-24","scope":"insider"},{"id":2726060,"accession":"0000899243-20-011020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-011020","line_url":"/filing/0000899243-20-011020#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":62.47,"price_display":"62.47","price_state":"stated","total_value":1249400.0,"total_display":"1,249,400.00","total_whole":"1,249,400","shares_owned_after":1309523.0,"shares_owned_after_display":"1,309,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-20","scope":"insider"},{"id":2328232,"accession":"0000899243-20-010812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-010812","line_url":"/filing/0000899243-20-010812#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12537.0,"shares_display":"12,537","price_per_share":62.58,"price_display":"62.58","price_state":"stated","total_value":784565.46,"total_display":"784,565.46","total_whole":"784,565","shares_owned_after":1329523.0,"shares_owned_after_display":"1,329,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-04-15","scope":"insider"},{"id":2328226,"accession":"0000899243-20-010812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-010812","line_url":"/filing/0000899243-20-010812#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6261.0,"shares_display":"6,261","price_per_share":62.99,"price_display":"62.99","price_state":"stated","total_value":394380.39,"total_display":"394,380.39","total_whole":"394,380","shares_owned_after":1342060.0,"shares_owned_after_display":"1,342,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-14","filed_date":"2020-04-15","scope":"insider"},{"id":2328223,"accession":"0000899243-20-010812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-010812","line_url":"/filing/0000899243-20-010812#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17071.0,"shares_display":"17,071","price_per_share":62.25,"price_display":"62.25","price_state":"stated","total_value":1062669.75,"total_display":"1,062,669.75","total_whole":"1,062,670","shares_owned_after":1348321.0,"shares_owned_after_display":"1,348,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-15","scope":"insider"},{"id":2207532,"accession":"0000899243-20-010651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-010651","line_url":"/filing/0000899243-20-010651#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23716.0,"shares_display":"23,716","price_per_share":61.83,"price_display":"61.83","price_state":"stated","total_value":1466360.28,"total_display":"1,466,360.28","total_whole":"1,466,360","shares_owned_after":1365392.0,"shares_owned_after_display":"1,365,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-10","scope":"insider"},{"id":2207529,"accession":"0000899243-20-010651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-010651","line_url":"/filing/0000899243-20-010651","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37362.0,"shares_display":"37,362","price_per_share":61.134711203897005,"price_display":"61.13","price_state":"stated","total_value":2284115.08,"total_display":"2,284,115.08","total_whole":"2,284,115","shares_owned_after":1389108.0,"shares_owned_after_display":"1,389,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider","n_lines":2},{"id":3032775,"accession":"0000899243-20-010540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-010540","line_url":"/filing/0000899243-20-010540#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14336.0,"shares_display":"14,336","price_per_share":60.76,"price_display":"60.76","price_state":"stated","total_value":871055.36,"total_display":"871,055.36","total_whole":"871,055","shares_owned_after":1426470.0,"shares_owned_after_display":"1,426,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-07","filed_date":"2020-04-08","scope":"insider"},{"id":3032769,"accession":"0000899243-20-010540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-010540","line_url":"/filing/0000899243-20-010540#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28240.0,"shares_display":"28,240","price_per_share":60.5,"price_display":"60.50","price_state":"stated","total_value":1708520.0,"total_display":"1,708,520.00","total_whole":"1,708,520","shares_owned_after":1440806.0,"shares_owned_after_display":"1,440,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-06","filed_date":"2020-04-08","scope":"insider"},{"id":2281755,"accession":"0000899243-20-006361","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-006361","line_url":"/filing/0000899243-20-006361#line-7","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9837.0,"shares_display":"9,837","price_per_share":56.97,"price_display":"56.97","price_state":"stated","total_value":560413.89,"total_display":"560,413.89","total_whole":"560,414","shares_owned_after":1469046.0,"shares_owned_after_display":"1,469,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-02-28","scope":"insider"},{"id":2281748,"accession":"0000899243-20-006361","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-006361","line_url":"/filing/0000899243-20-006361#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13619.0,"shares_display":"13,619","price_per_share":58.7,"price_display":"58.70","price_state":"stated","total_value":799435.3,"total_display":"799,435.30","total_whole":"799,435","shares_owned_after":1472943.0,"shares_owned_after_display":"1,472,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider"},{"id":3032395,"accession":"0000899243-20-005665","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-005665","line_url":"/filing/0000899243-20-005665#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18567.0,"shares_display":"18,567","price_per_share":64.9,"price_display":"64.90","price_state":"stated","total_value":1204998.3,"total_display":"1,204,998.30","total_whole":"1,204,998","shares_owned_after":1479018.0,"shares_owned_after_display":"1,479,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-21","filed_date":"2020-02-24","scope":"insider"},{"id":3032392,"accession":"0000899243-20-005665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005665","line_url":"/filing/0000899243-20-005665#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4751.0,"shares_display":"4,751","price_per_share":64.9,"price_display":"64.90","price_state":"stated","total_value":308339.9,"total_display":"308,339.90","total_whole":"308,340","shares_owned_after":1479018.0,"shares_owned_after_display":"1,479,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-20","filed_date":"2020-02-24","scope":"insider"},{"id":2207035,"accession":"0000899243-20-005195","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-005195","line_url":"/filing/0000899243-20-005195#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15614.0,"shares_display":"15,614","price_per_share":63.9,"price_display":"63.90","price_state":"stated","total_value":997734.6,"total_display":"997,734.60","total_whole":"997,735","shares_owned_after":1479018.0,"shares_owned_after_display":"1,479,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-19","scope":"insider"},{"id":2207033,"accession":"0000899243-20-005195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005195","line_url":"/filing/0000899243-20-005195#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4386.0,"shares_display":"4,386","price_per_share":63.9,"price_display":"63.90","price_state":"stated","total_value":280265.4,"total_display":"280,265.40","total_whole":"280,265","shares_owned_after":1479018.0,"shares_owned_after_display":"1,479,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-19","scope":"insider"},{"id":2540998,"accession":"0000899243-20-004522","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-004522","line_url":"/filing/0000899243-20-004522#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13720.0,"shares_display":"13,720","price_per_share":62.9,"price_display":"62.90","price_state":"stated","total_value":862988.0,"total_display":"862,988.00","total_whole":"862,988","shares_owned_after":1479018.0,"shares_owned_after_display":"1,479,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-02-13","scope":"insider"},{"id":2540992,"accession":"0000899243-20-004522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-004522","line_url":"/filing/0000899243-20-004522#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6280.0,"shares_display":"6,280","price_per_share":62.9,"price_display":"62.90","price_state":"stated","total_value":395012.0,"total_display":"395,012.00","total_whole":"395,012","shares_owned_after":1479018.0,"shares_owned_after_display":"1,479,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-13","scope":"insider"},{"id":3160576,"accession":"0000899243-20-003714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-003714","line_url":"/filing/0000899243-20-003714#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11684.0,"shares_display":"11,684","price_per_share":61.9,"price_display":"61.90","price_state":"stated","total_value":723239.6,"total_display":"723,239.60","total_whole":"723,240","shares_owned_after":1419018.0,"shares_owned_after_display":"1,419,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-07","scope":"insider"},{"id":3160570,"accession":"0000899243-20-003714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-003714","line_url":"/filing/0000899243-20-003714#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48316.0,"shares_display":"48,316","price_per_share":60.66,"price_display":"60.66","price_state":"stated","total_value":2930848.56,"total_display":"2,930,848.56","total_whole":"2,930,849","shares_owned_after":1430702.0,"shares_owned_after_display":"1,430,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider"},{"id":7859744,"accession":"0001019056-19-000476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-19-000476","line_url":"/filing/0001019056-19-000476#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.7552,"price_display":"0.76","price_state":"stated","total_value":75520.0,"total_display":"75,520.00","total_whole":"75,520","shares_owned_after":1124536.0,"shares_owned_after_display":"1,124,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8749310,"accession":"0001593968-19-001685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001685","line_url":"/filing/0001593968-19-001685#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55015.0,"shares_display":"55,015","price_per_share":0.8336,"price_display":"0.83","price_state":"stated","total_value":45860.504,"total_display":"45,860.50","total_whole":"45,861","shares_owned_after":1024536.0,"shares_owned_after_display":"1,024,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-07-30","scope":"insider"},{"id":8018988,"accession":"0001593968-19-001652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001652","line_url":"/filing/0001593968-19-001652#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.8996,"price_display":"0.90","price_state":"stated","total_value":8996.0,"total_display":"8,996.00","total_whole":"8,996","shares_owned_after":969521.0,"shares_owned_after_display":"969,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-23","filed_date":"2019-07-24","scope":"insider"},{"id":8246394,"accession":"0001593968-19-001649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001649","line_url":"/filing/0001593968-19-001649#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.8867,"price_display":"0.89","price_state":"stated","total_value":26601.0,"total_display":"26,601.00","total_whole":"26,601","shares_owned_after":959521.0,"shares_owned_after_display":"959,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-23","scope":"insider"},{"id":8354192,"accession":"0001593968-19-001645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001645","line_url":"/filing/0001593968-19-001645#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26460.0,"shares_display":"26,460","price_per_share":0.8972,"price_display":"0.90","price_state":"stated","total_value":23739.912,"total_display":"23,739.91","total_whole":"23,740","shares_owned_after":929521.0,"shares_owned_after_display":"929,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-19","filed_date":"2019-07-19","scope":"insider"},{"id":8246388,"accession":"0001593968-19-001642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001642","line_url":"/filing/0001593968-19-001642#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14404.0,"shares_display":"14,404","price_per_share":0.8745,"price_display":"0.87","price_state":"stated","total_value":12596.298,"total_display":"12,596.30","total_whole":"12,596","shares_owned_after":903061.0,"shares_owned_after_display":"903,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-18","filed_date":"2019-07-18","scope":"insider"},{"id":7988570,"accession":"0001593968-19-001640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001640","line_url":"/filing/0001593968-19-001640#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19136.0,"shares_display":"19,136","price_per_share":0.8729,"price_display":"0.87","price_state":"stated","total_value":16703.8144,"total_display":"16,703.81","total_whole":"16,704","shares_owned_after":888657.0,"shares_owned_after_display":"888,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-17","filed_date":"2019-07-18","scope":"insider"},{"id":8193093,"accession":"0001593968-19-001632","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001632","line_url":"/filing/0001593968-19-001632#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11375.0,"shares_display":"11,375","price_per_share":0.8494,"price_display":"0.85","price_state":"stated","total_value":9661.925,"total_display":"9,661.92","total_whole":"9,662","shares_owned_after":869521.0,"shares_owned_after_display":"869,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-16","filed_date":"2019-07-16","scope":"insider"},{"id":8193078,"accession":"0001593968-19-001618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001618","line_url":"/filing/0001593968-19-001618#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Board of Directors","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14691.0,"shares_display":"14,691","price_per_share":0.8477,"price_display":"0.85","price_state":"stated","total_value":12453.5607,"total_display":"12,453.56","total_whole":"12,454","shares_owned_after":858146.0,"shares_owned_after_display":"858,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-12","scope":"insider"},{"id":7809492,"accession":"0001019056-19-000402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019056-19-000402","line_url":"/filing/0001019056-19-000402#line-1","is_derivative":false,"issuer_cik":"0001380185","issuer_name":"Aptevo Therapeutics Inc.","issuer_ticker":"APVO","issuer_name_source":null,"issuer_url":"/issuer/0001380185","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18919.0,"shares_display":"18,919","price_per_share":0.8488,"price_display":"0.85","price_state":"stated","total_value":16058.4472,"total_display":"16,058.45","total_whole":"16,058","shares_owned_after":843455.0,"shares_owned_after_display":"843,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-11","scope":"insider"},{"id":8690318,"accession":"0000899243-19-005313","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-005313","line_url":"/filing/0000899243-19-005313#line-9","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6987.0,"shares_display":"6,987","price_per_share":58.47,"price_display":"58.47","price_state":"stated","total_value":408529.89,"total_display":"408,529.89","total_whole":"408,530","shares_owned_after":1473122.0,"shares_owned_after_display":"1,473,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-02-28","scope":"insider"},{"id":8690303,"accession":"0000899243-19-005313","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-005313","line_url":"/filing/0000899243-19-005313#line-6","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10369.0,"shares_display":"10,369","price_per_share":58.24,"price_display":"58.24","price_state":"stated","total_value":603890.56,"total_display":"603,890.56","total_whole":"603,891","shares_owned_after":1472801.0,"shares_owned_after_display":"1,472,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-27","filed_date":"2019-02-28","scope":"insider"},{"id":8690292,"accession":"0000899243-19-005313","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-005313","line_url":"/filing/0000899243-19-005313#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10369.0,"shares_display":"10,369","price_per_share":59.65,"price_display":"59.65","price_state":"stated","total_value":618510.85,"total_display":"618,510.85","total_whole":"618,511","shares_owned_after":1478306.0,"shares_owned_after_display":"1,478,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"},{"id":9204630,"accession":"0000899243-19-004317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-004317","line_url":"/filing/0000899243-19-004317#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20832.0,"shares_display":"20,832","price_per_share":69.59,"price_display":"69.59","price_state":"stated","total_value":1449698.88,"total_display":"1,449,698.88","total_whole":"1,449,699","shares_owned_after":1488675.0,"shares_owned_after_display":"1,488,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2019-02-20","scope":"insider"},{"id":5981389,"accession":"0000899243-18-029754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-029754","line_url":"/filing/0000899243-18-029754#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20832.0,"shares_display":"20,832","price_per_share":69.59,"price_display":"69.59","price_state":"stated","total_value":1449698.88,"total_display":"1,449,698.88","total_whole":"1,449,699","shares_owned_after":1407670.0,"shares_owned_after_display":"1,407,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-11-28","scope":"insider"},{"id":5981386,"accession":"0000899243-18-029754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-029754","line_url":"/filing/0000899243-18-029754#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":69.96,"price_display":"69.96","price_state":"stated","total_value":1749000.0,"total_display":"1,749,000.00","total_whole":"1,749,000","shares_owned_after":1428502.0,"shares_owned_after_display":"1,428,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-26","filed_date":"2018-11-28","scope":"insider"},{"id":6382083,"accession":"0000899243-18-029546","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-029546","line_url":"/filing/0000899243-18-029546#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001380185","owner_name":"El-Hibri Fuad","owner_display_name":"El-Hibri Fuad","owner_url":"/insider/0001380185","role":"Director, Officer (Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15173.0,"shares_display":"15,173","price_per_share":70.03,"price_display":"70.03","price_state":"stated","total_value":1062565.19,"total_display":"1,062,565.19","total_whole":"1,062,565","shares_owned_after":1453502.0,"shares_owned_after_display":"1,453,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-20","filed_date":"2018-11-21","scope":"insider"}],"collapsed":true,"next_cursor":"2018-11-20|6382083","ledger_fault":false,"count":{"value":336,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":326,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":336},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367644","name":"Emergent BioSolutions Inc.","url":"/issuer/0001367644","role":"Director, Officer (Chairman), Ten percent owner","n_filings":94,"first_seen":"2008-07-28","last_seen":"2020-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001671584","name":"Aptevo Therapeutics Inc.","url":"/issuer/0001671584","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2019-07-11","last_seen":"2019-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380185","retrieved_at":"2026-08-22T13:25:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}